The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Granisetron Market Research Report 2025
Synopsis
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
The global Granisetron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Granisetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Granisetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Granisetron in Chemotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Granisetron include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, Teva, Cipla, Sandoz, Wockhardt and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Granisetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granisetron.
Report Scope
The Granisetron market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Granisetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Granisetron companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
Segment by Type
Transdermal system
Injection
Oral
Segment by Application
Chemotherapy
Post operative
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Granisetron companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
The global Granisetron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Granisetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Granisetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Granisetron in Chemotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Granisetron include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, Teva, Cipla, Sandoz, Wockhardt and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Granisetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granisetron.
Report Scope
The Granisetron market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Granisetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Granisetron companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
Segment by Type
Transdermal system
Injection
Oral
Segment by Application
Chemotherapy
Post operative
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Granisetron companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Granisetron Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Transdermal system
1.2.3 Injection
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Granisetron Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chemotherapy
1.3.3 Post operative
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Granisetron Market Perspective (2019-2030)
2.2 Granisetron Growth Trends by Region
2.2.1 Global Granisetron Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Granisetron Historic Market Size by Region (2019-2024)
2.2.3 Granisetron Forecasted Market Size by Region (2025-2030)
2.3 Granisetron Market Dynamics
2.3.1 Granisetron Industry Trends
2.3.2 Granisetron Market Drivers
2.3.3 Granisetron Market Challenges
2.3.4 Granisetron Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Granisetron Players by Revenue
3.1.1 Global Top Granisetron Players by Revenue (2019-2024)
3.1.2 Global Granisetron Revenue Market Share by Players (2019-2024)
3.2 Global Granisetron Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Granisetron Revenue
3.4 Global Granisetron Market Concentration Ratio
3.4.1 Global Granisetron Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Granisetron Revenue in 2023
3.5 Granisetron Key Players Head office and Area Served
3.6 Key Players Granisetron Product Solution and Service
3.7 Date of Enter into Granisetron Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Granisetron Breakdown Data by Type
4.1 Global Granisetron Historic Market Size by Type (2019-2024)
4.2 Global Granisetron Forecasted Market Size by Type (2025-2030)
5 Granisetron Breakdown Data by Application
5.1 Global Granisetron Historic Market Size by Application (2019-2024)
5.2 Global Granisetron Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Granisetron Market Size (2019-2030)
6.2 North America Granisetron Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Granisetron Market Size by Country (2019-2024)
6.4 North America Granisetron Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Granisetron Market Size (2019-2030)
7.2 Europe Granisetron Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Granisetron Market Size by Country (2019-2024)
7.4 Europe Granisetron Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Granisetron Market Size (2019-2030)
8.2 Asia-Pacific Granisetron Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Granisetron Market Size by Region (2019-2024)
8.4 Asia-Pacific Granisetron Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Granisetron Market Size (2019-2030)
9.2 Latin America Granisetron Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Granisetron Market Size by Country (2019-2024)
9.4 Latin America Granisetron Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Granisetron Market Size (2019-2030)
10.2 Middle East & Africa Granisetron Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Granisetron Market Size by Country (2019-2024)
10.4 Middle East & Africa Granisetron Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kyowa Kirin
11.1.1 Kyowa Kirin Company Detail
11.1.2 Kyowa Kirin Business Overview
11.1.3 Kyowa Kirin Granisetron Introduction
11.1.4 Kyowa Kirin Revenue in Granisetron Business (2019-2024)
11.1.5 Kyowa Kirin Recent Development
11.2 Heron Therapeutics
11.2.1 Heron Therapeutics Company Detail
11.2.2 Heron Therapeutics Business Overview
11.2.3 Heron Therapeutics Granisetron Introduction
11.2.4 Heron Therapeutics Revenue in Granisetron Business (2019-2024)
11.2.5 Heron Therapeutics Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Granisetron Introduction
11.3.4 Fresenius Kabi Revenue in Granisetron Business (2019-2024)
11.3.5 Fresenius Kabi Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Detail
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Granisetron Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2019-2024)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Granisetron Introduction
11.5.4 Teva Revenue in Granisetron Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Granisetron Introduction
11.6.4 Cipla Revenue in Granisetron Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Detail
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Granisetron Introduction
11.7.4 Sandoz Revenue in Granisetron Business (2019-2024)
11.7.5 Sandoz Recent Development
11.8 Wockhardt
11.8.1 Wockhardt Company Detail
11.8.2 Wockhardt Business Overview
11.8.3 Wockhardt Granisetron Introduction
11.8.4 Wockhardt Revenue in Granisetron Business (2019-2024)
11.8.5 Wockhardt Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Granisetron Introduction
11.9.4 Mylan Revenue in Granisetron Business (2019-2024)
11.9.5 Mylan Recent Development
11.10 APOTEX
11.10.1 APOTEX Company Detail
11.10.2 APOTEX Business Overview
11.10.3 APOTEX Granisetron Introduction
11.10.4 APOTEX Revenue in Granisetron Business (2019-2024)
11.10.5 APOTEX Recent Development
11.11 Dr.Reddy's
11.11.1 Dr.Reddy's Company Detail
11.11.2 Dr.Reddy's Business Overview
11.11.3 Dr.Reddy's Granisetron Introduction
11.11.4 Dr.Reddy's Revenue in Granisetron Business (2019-2024)
11.11.5 Dr.Reddy's Recent Development
11.12 Bluepharma
11.12.1 Bluepharma Company Detail
11.12.2 Bluepharma Business Overview
11.12.3 Bluepharma Granisetron Introduction
11.12.4 Bluepharma Revenue in Granisetron Business (2019-2024)
11.12.5 Bluepharma Recent Development
11.13 Natco Pharma
11.13.1 Natco Pharma Company Detail
11.13.2 Natco Pharma Business Overview
11.13.3 Natco Pharma Granisetron Introduction
11.13.4 Natco Pharma Revenue in Granisetron Business (2019-2024)
11.13.5 Natco Pharma Recent Development
11.14 Akorn
11.14.1 Akorn Company Detail
11.14.2 Akorn Business Overview
11.14.3 Akorn Granisetron Introduction
11.14.4 Akorn Revenue in Granisetron Business (2019-2024)
11.14.5 Akorn Recent Development
11.15 Taro Pharmaceutical
11.15.1 Taro Pharmaceutical Company Detail
11.15.2 Taro Pharmaceutical Business Overview
11.15.3 Taro Pharmaceutical Granisetron Introduction
11.15.4 Taro Pharmaceutical Revenue in Granisetron Business (2019-2024)
11.15.5 Taro Pharmaceutical Recent Development
11.16 Aurobindo
11.16.1 Aurobindo Company Detail
11.16.2 Aurobindo Business Overview
11.16.3 Aurobindo Granisetron Introduction
11.16.4 Aurobindo Revenue in Granisetron Business (2019-2024)
11.16.5 Aurobindo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Granisetron Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Transdermal system
Table 3. Key Players of Injection
Table 4. Key Players of Oral
Table 5. Global Granisetron Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Granisetron Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Granisetron Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Granisetron Market Share by Region (2019-2024)
Table 9. Global Granisetron Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Granisetron Market Share by Region (2025-2030)
Table 11. Granisetron Market Trends
Table 12. Granisetron Market Drivers
Table 13. Granisetron Market Challenges
Table 14. Granisetron Market Restraints
Table 15. Global Granisetron Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Granisetron Market Share by Players (2019-2024)
Table 17. Global Top Granisetron Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granisetron as of 2023)
Table 18. Ranking of Global Top Granisetron Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Granisetron Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Granisetron Product Solution and Service
Table 22. Date of Enter into Granisetron Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Granisetron Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Granisetron Revenue Market Share by Type (2019-2024)
Table 26. Global Granisetron Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Granisetron Revenue Market Share by Type (2025-2030)
Table 28. Global Granisetron Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Granisetron Revenue Market Share by Application (2019-2024)
Table 30. Global Granisetron Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Granisetron Revenue Market Share by Application (2025-2030)
Table 32. North America Granisetron Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Granisetron Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Granisetron Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Granisetron Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Granisetron Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Granisetron Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Granisetron Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Granisetron Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Granisetron Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Granisetron Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Granisetron Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Granisetron Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Granisetron Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Granisetron Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Granisetron Market Size by Country (2025-2030) & (US$ Million)
Table 47. Kyowa Kirin Company Detail
Table 48. Kyowa Kirin Business Overview
Table 49. Kyowa Kirin Granisetron Product
Table 50. Kyowa Kirin Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 51. Kyowa Kirin Recent Development
Table 52. Heron Therapeutics Company Detail
Table 53. Heron Therapeutics Business Overview
Table 54. Heron Therapeutics Granisetron Product
Table 55. Heron Therapeutics Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 56. Heron Therapeutics Recent Development
Table 57. Fresenius Kabi Company Detail
Table 58. Fresenius Kabi Business Overview
Table 59. Fresenius Kabi Granisetron Product
Table 60. Fresenius Kabi Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 61. Fresenius Kabi Recent Development
Table 62. Hikma Pharmaceuticals Company Detail
Table 63. Hikma Pharmaceuticals Business Overview
Table 64. Hikma Pharmaceuticals Granisetron Product
Table 65. Hikma Pharmaceuticals Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 66. Hikma Pharmaceuticals Recent Development
Table 67. Teva Company Detail
Table 68. Teva Business Overview
Table 69. Teva Granisetron Product
Table 70. Teva Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Cipla Company Detail
Table 73. Cipla Business Overview
Table 74. Cipla Granisetron Product
Table 75. Cipla Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 76. Cipla Recent Development
Table 77. Sandoz Company Detail
Table 78. Sandoz Business Overview
Table 79. Sandoz Granisetron Product
Table 80. Sandoz Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 81. Sandoz Recent Development
Table 82. Wockhardt Company Detail
Table 83. Wockhardt Business Overview
Table 84. Wockhardt Granisetron Product
Table 85. Wockhardt Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 86. Wockhardt Recent Development
Table 87. Mylan Company Detail
Table 88. Mylan Business Overview
Table 89. Mylan Granisetron Product
Table 90. Mylan Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. APOTEX Company Detail
Table 93. APOTEX Business Overview
Table 94. APOTEX Granisetron Product
Table 95. APOTEX Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 96. APOTEX Recent Development
Table 97. Dr.Reddy's Company Detail
Table 98. Dr.Reddy's Business Overview
Table 99. Dr.Reddy's Granisetron Product
Table 100. Dr.Reddy's Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 101. Dr.Reddy's Recent Development
Table 102. Bluepharma Company Detail
Table 103. Bluepharma Business Overview
Table 104. Bluepharma Granisetron Product
Table 105. Bluepharma Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 106. Bluepharma Recent Development
Table 107. Natco Pharma Company Detail
Table 108. Natco Pharma Business Overview
Table 109. Natco Pharma Granisetron Product
Table 110. Natco Pharma Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 111. Natco Pharma Recent Development
Table 112. Akorn Company Detail
Table 113. Akorn Business Overview
Table 114. Akorn Granisetron Product
Table 115. Akorn Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 116. Akorn Recent Development
Table 117. Taro Pharmaceutical Company Detail
Table 118. Taro Pharmaceutical Business Overview
Table 119. Taro Pharmaceutical Granisetron Product
Table 120. Taro Pharmaceutical Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 121. Taro Pharmaceutical Recent Development
Table 122. Aurobindo Company Detail
Table 123. Aurobindo Business Overview
Table 124. Aurobindo Granisetron Product
Table 125. Aurobindo Revenue in Granisetron Business (2019-2024) & (US$ Million)
Table 126. Aurobindo Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Granisetron Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Granisetron Market Share by Type: 2023 VS 2030
Figure 3. Transdermal system Features
Figure 4. Injection Features
Figure 5. Oral Features
Figure 6. Global Granisetron Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Granisetron Market Share by Application: 2023 VS 2030
Figure 8. Chemotherapy Case Studies
Figure 9. Post operative Case Studies
Figure 10. Granisetron Report Years Considered
Figure 11. Global Granisetron Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Granisetron Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Granisetron Market Share by Region: 2023 VS 2030
Figure 14. Global Granisetron Market Share by Players in 2023
Figure 15. Global Top Granisetron Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granisetron as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Granisetron Revenue in 2023
Figure 17. North America Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Granisetron Market Share by Country (2019-2030)
Figure 19. United States Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Granisetron Market Share by Country (2019-2030)
Figure 23. Germany Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Granisetron Market Share by Region (2019-2030)
Figure 31. China Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Granisetron Market Share by Country (2019-2030)
Figure 39. Mexico Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Granisetron Market Share by Country (2019-2030)
Figure 43. Turkey Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Granisetron Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Kyowa Kirin Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 46. Heron Therapeutics Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 47. Fresenius Kabi Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 48. Hikma Pharmaceuticals Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 49. Teva Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 50. Cipla Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 51. Sandoz Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 52. Wockhardt Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 53. Mylan Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 54. APOTEX Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 55. Dr.Reddy's Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 56. Bluepharma Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 57. Natco Pharma Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 58. Akorn Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 59. Taro Pharmaceutical Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 60. Aurobindo Revenue Growth Rate in Granisetron Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
